Deca-Durabolin Orgaject

Riik: Uus-Meremaa

keel: inglise

Allikas: Medsafe (Medicines Safety Authority)

Toimeaine:

Nandrolone decanoate 50 mg/mL

Saadav alates:

Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics

INN (Rahvusvaheline Nimetus):

Nandrolone decanoate 50 mg/mL

Annus:

50 mg/mL

Ravimvorm:

Solution for injection

Koostis:

Active: Nandrolone decanoate 50 mg/mL Excipient: Arachis oil Benzyl alcohol

Ühikuid pakis:

Ampoule, glass, 1 mL

Klass:

Prescription

Retsepti tüüp:

Prescription

Valmistatud:

Aspen Oss B.V

Näidustused:

DECA-DURABOLIN can be used for the treatment of osteoporosis; for the palliative treatment of selected cases of disseminated mammary carcinoma in women and as an adjunct to specific therapies and dietary measures in pathologic conditions characterized by a negative nitrogen balance.

Toote kokkuvõte:

Package - Contents - Shelf Life: Ampoule, glass, - 1 mL - 5 years from date of manufacture stored at or below 25°C - Syringe, Orgaject disposible - 1 mL - 36 months from date of manufacture stored at or below 25°C

Loa andmise kuupäev:

1969-12-31

Toote omadused

NEW ZEALAND DATA SHEET 
Deca-Durabolin D130424 Version 3.1 

Page1 
DECA-DURABOLIN

PRESENTATION 
Each pre-filled syringe contains 1 mL of 25
mg/ mL nandrolone decanoate. 
Each pre-filled syringe contains 1 mL of 50 mg/ mL
nandrolone decanoate. 
Each pre-filled syringe is affixed with a needle 
CLOSED BY A NEEDLE SHIELD OF NATURAL RUBBER LATEX 
(See warnings and precautions for use). 
Each ampoule contains 1 ml of 50 mg/ml nandrolone decanoate. 

Each ml of the yellow, oily solution contains: 
25 or 50 mg nandrolone decanoate. 

USES 

ACTIONS 
DECA-DURABOLIN is an injectable anabolic preparation.  The
pharmacologically active substance is 
nandrolone.  The decanoate ester gives the preparation a
duration of action of about three weeks after 
injection. 
Nandrolone is chemically related to the male hormone.  Compared
to testosterone, it has an enhanced 
anabolic and a reduced androgenic activity. 
This has been demonstrated in animal bioassays and 
explained by receptor binding studies. 
The low androgenicity of nandrolone is confirmed in clinical 
use. 
In the human, DECA-DURABOLIN has been shown to
positively influence calcium metabolism and to 
increase bone mass in osteoporosis.  In women with disseminated
mammary carcinoma, DECA-
DURABOLIN has been reported to produce objective
regressions for many months.  Furthermore, 
DECA-DURABOLIN has a nitrogen-saving action. 
This effect on protein metabolism has been established
by metabolic studies and is utilized 
therapeutically in conditions where
a protein deficiency exists such as during
chronic debilitating 
diseases and after major surgery and severe trauma.  In these
conditions, DECA-DURABOLIN serves 
as a supportive adjunct to
specific therapies and dietary measures as well as parenteral nutrition. 
Androgenic effects (e.g. virilisation) are relatively uncommon
at